Autologous umbilical cord blood-derived mononuclear cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous umbilical cord blood-derived mononuclear cells, covering 2025-07-08 to 2025-07-08. Get the full timeline:
Most recent: Clinical Trial Update: Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Repair of Hypoplastic Left Heart Syndrome [Phase 2]